Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hinz M, Stein A, Cole T, McDougall B, Westaway M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
parkinson’s disease
l-dopa
carbidopa
b6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/c61f4d470b52431b8fbaae454c1d5cca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c61f4d470b52431b8fbaae454c1d5cca
record_format dspace
spelling oai:doaj.org-article:c61f4d470b52431b8fbaae454c1d5cca2021-12-02T15:21:31ZParkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]1178-2021https://doaj.org/article/c61f4d470b52431b8fbaae454c1d5cca2020-04-01T00:00:00Zhttps://www.dovepress.com/eoc-parkinsonrsquos-disease-managing-reversible-neurodegenera-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors, and the level of information provided on methodology, study data and process of institutional ethical approval for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original articleHinz MStein ACole TMcDougall BWestaway MDove Medical Pressarticleparkinson’s diseasel-dopacarbidopab6neurodegenerationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1061-1062 (2020)
institution DOAJ
collection DOAJ
language EN
topic parkinson’s disease
l-dopa
carbidopa
b6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle parkinson’s disease
l-dopa
carbidopa
b6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hinz M
Stein A
Cole T
McDougall B
Westaway M
Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
description Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors, and the level of information provided on methodology, study data and process of institutional ethical approval for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original article
format article
author Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_facet Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_sort Hinz M
title Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
title_short Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
title_full Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
title_fullStr Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
title_full_unstemmed Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
title_sort parkinson’s disease managing reversible neurodegeneration [expression of concern]
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/c61f4d470b52431b8fbaae454c1d5cca
work_keys_str_mv AT hinzm parkinsonrsquosdiseasemanagingreversibleneurodegenerationexpressionofconcern
AT steina parkinsonrsquosdiseasemanagingreversibleneurodegenerationexpressionofconcern
AT colet parkinsonrsquosdiseasemanagingreversibleneurodegenerationexpressionofconcern
AT mcdougallb parkinsonrsquosdiseasemanagingreversibleneurodegenerationexpressionofconcern
AT westawaym parkinsonrsquosdiseasemanagingreversibleneurodegenerationexpressionofconcern
_version_ 1718387421212573696

Ejemplares similares